Related references
Note: Only part of the references are listed.Excellent long-term survival of 170 patients with Waldenstrom's macroglobulinemia treated in private oncology practices and a university hospital
M. Hensel et al.
ANNALS OF HEMATOLOGY (2012)
No significant improvement in the outcome of patients with Waldenstrom's macroglobulinemia treated over the last 25 years
Efstathios Kastritis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstrom's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Alice Garnier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
High-Dose Therapy and Autologous Stem-Cell Transplantation in Waldenstrom Macroglobulinemia: The Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Allogeneic Stem-Cell Transplantation in Patients With Waldenstrom Macroglobulinemia: Report From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia
Sigurdur Y. Kristinsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term outcomes to fludarabine and rituximab in Waldenstrom macroglobulinemia
Steven P. Treon et al.
BLOOD (2009)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Update on Treatment Recommendations From the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients:: a population-based study in Sweden
Sigurdur Y. Kristinsson et al.
BLOOD (2008)
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study
Maria H. Gilleece et al.
HEMATOLOGY (2008)
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003
Ingemar Turesson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Novel agents in the treatment of Waldenstrom's macroglobulinemia
Steven P. Treon et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Sigurdur Yngvi Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
Christine I. Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: Results of WMCTG trial 03-248
Steven P. Treon et al.
CLINICAL CANCER RESEARCH (2007)
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia
Athanasios Anagnostopoulos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Interpreting trends in cancer patient survival
P. W. Dickman et al.
JOURNAL OF INTERNAL MEDICINE (2006)
CHOP plus Rituximab therapy in Waldenstrom's macroglobulinemia
SP Treon et al.
CLINICAL LYMPHOMA (2005)
Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia:: A two-institution study
M Björkholm et al.
SEMINARS IN ONCOLOGY (2003)
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia
G Merlini et al.
SEMINARS IN ONCOLOGY (2003)
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003)
MV Dhodapkar et al.
SEMINARS IN ONCOLOGY (2003)
Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
RFJ Schop et al.
BLOOD (2002)
Treatment of Waldenstrom's macroglobulinemia with rituximab
MA Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Waldenstrom macroglobulinaemia:: presenting features and outcome in a series with 217 cases
R García-Sanz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Treatment of Waldenstrom's macroglobulinemia with thalidomide
MA Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Waldenstrom's macroglobulinemia: Clinical features, complications, and management
MA Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
